SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

For the first time since 1952, publication of the CDC's Morbidity and Mortality Weekly Report was halted. It returned on Feb.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

February 6 (SeeNews) - Montenegrin firms Energy 2 and N1 need to prepare environmental impact assessment (EIA) studies for wind farm projects with a total installed capacity of 402.6 MW in the ...

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...